Alfuzosin Hydrochloride is a uroselective alpha-1 adrenergic receptor blocker that relaxes smooth muscle in the prostate and bladder neck, providing symptomatic relief in benign prostatic hyperplasia. Simson Pharma's Alfuzosin Hydrochloride reference standard and impurities support assay and degradation-product testing for this urology-focused therapy.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Alfuzosin Hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.